Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Journal of Affective Disorders, 2023Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study
Zuo C., Zhuang Z., Yang P. et al.
Olink Target 96
Cardiovascular Research, 2023Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins
Janssen A., van Heck J., Stienstra R. et al.
JCI Insight, 2023High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
Vadaq N., Zhang Y., Vos W. et al.
Olink Explore 3072/384
Computational and Structural Biotechnology Journal, 2023Network-based drug repurposing for potential stroke therapy
Wu Q., Chen C., Liu W. et al.
International Journal of Molecular Sciences, 2023Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling
Sîrbe C., Badii M., Crişan T. et al.
Intensive Care Medicine, 2023Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial
Roquilly A., Francois B., Huet O. et al.
International Journal of Molecular Sciences, 2023Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study
Mesleh A., Ehtewish H., de la Fuente A. et al.
Oxford Open Immunology, 2023Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance
Rodriguez L., Pou C., Lakshmikanth T. et al.
European Journal of Heart Failure, 2023A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trial
Kobayashi M., Huttin O., Ferreira J. et al.
Clinical and Experimental Medicine, 2023Unique immune and inflammatory cytokine profiles may define long COVID syndrome
Allan-Blitz L., Akbari O., Kojima N. et al.
Journal of Cachexia, Sarcopenia and Muscle, 2023Direct electrical stimulation impacts on neuromuscular junction morphology on both stimulated and unstimulated contralateral soleus
Lee Y., Cacciani N., Wen Y. et al.
Olink Target 96 Mouse
Gastroenterology, 2023Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study
Lee B., Jones E., Manohar M. et al.
British Journal of Dermatology, 2023Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis
Quaade A., Wang X., Sølberg J. et al.
International Journal of Molecular Sciences, 2023Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies
Liu H., Santos L., Smith S.
Nature Medicine, 2023Body composition and lung cancer-associated cachexia in TRACERx
Al-Sawaf O., Weiss J., Skrzypski M. et al.
Journal of Immunological Methods, 2023Comparison of multiplexed protein analysis platforms for the detection of biomarkers in the nasal epithelial lining fluid of healthy subjects
Zetlen H., Cao K., Schichlein K. et al.
Journal of Leukocyte Biology, 2023Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection
Bennett S., Davila C., Reyes Z. et al.
The Lancet Regional Health - Europe, 2023Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial
Dulfer E., Geckin B., Taks E. et al.
Journal of the American Academy of Dermatology, 2023Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin
Kim M., Del Duca E., Cheng J. et al.
Allergy, 2023Age of onset defines two distinct profiles of atopic dermatitis in adults
Facheris P., Da Rosa J., Pagan A. et al.
1945 publications
Items per page
661-680 of 1945 publications